Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pregabalin Add-on for Neuropathic Pain in Cervical Myelopathy
NCT03618589Phase 1Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Nov 2016
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of pregabalin in neuropathic pain (2 arms), sponsored by Seoul National University Hospital. Primary endpoints: Leeds Assessment of Neuropathic Symptoms and Signs at 2 months and Visual Analogue Scale at 2 months. Status: unknown.
02
Drugs
pregabalin
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT03618589.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03618589.